Comparative evaluation of different types of bariatric surgery
DOI:
https://doi.org/10.12775/JEHS.2022.12.04.016Keywords
Ghrelin, Leptin, Adiponectin, Resistin, Left gastric artery embolizationAbstract
Introduction. The use of bariatric surgery as a treatment for obesity has increased dramatically over the past few years. Because the results in obese patients with type 2 diabetes were so impressive, the International Diabetes Federation recommended considering bariatric surgery as an acceptable treatment option in patients with a BMI of 30-35 kg / m2 when diabetes cannot be adequately controlled with traditional therapies.
The aim of the study is to compare the results of bariatric surgery in patients with metabolic syndrome according to the dynamics of body mass index and major orexigenic and anorexigenic hormones.
Material and Methods. The results of surgical treatment of 19 patients with morbid obesity (5 men and 14 women) aged 44 ± 3.26 years with a body mass index ˃40 kg / m2 were evaluated. The control group consisted of 12 patients with normal body mass index and no manifestations of metabolic syndrome.
Results. Our study also demonstrated the positive effect of LGAE on hormonal parameters with a decrease in ghrelin and leptin. This helped reduce BMI by 10.12% after 6 months. At the same time there is an increase in adiponectin and resistin.
Conclusions. LGAE in patients with ghrelin-associated obesity is possible as an alternative intervention, given its good tolerability. Or, as the first preparatory stage of comprehensive surgical treatment in obese patients who are not good candidates for standard bariatric surgery.
References
Apovian, C. M., Garvey, W. T., & Ryan, D. H. (2015). Challenging obesity: Patient, provider, and expert perspectives on the roles of available and emerging nonsurgical therapies. Obesity (Silver Spring, Md.), 23 Suppl 2(0 2), S1–S26.
Arepally, A.; Barnett, B.; Montgomery, E.; Patel, T.H. Catheter-directed gastric artery chemical embolization for modulation of systemic ghrelin levels in a porcine model: Initial experience. Radiology 2007, 244, 138–143
Bai, Z. B., Qin, Y. L., Deng, G., Zhao, G. F., Zhong, B. Y., & Teng, G. J. (2018). Bariatric embolization of the left gastric arteries for the treatment of obesity: 9-month data in 5 patients. Obesity surgery, 28(4), 907-915.
Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346(21):1623–30.
Dixon, J. B., Zimmet, P., Alberti, K. G., Rubino, F., & International Diabetes Federation Taskforce on Epidemiology and Prevention (2011). Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabetic medicine : a journal of the British Diabetic Association, 28(6), 628–642.
Gagner M, Deitel M, Kalberer TL et al. The second international consensus summit for sleeve gastrectomy, March 19– –21, 2009. Surg Obes Relat Dis. 2009;5:476–485.
OECD (2019). The Heavy Burden of Obesity: The Economics of Prevention, OECD Health Policy Studies, OECD Publishing Paris
Seeley RJ, Chambers AP, Sandoval DA. The role of gut adaptation in the potent effects of multiple bariatric surgeries on obesity and diabetes. Cell Metab. 2015;21(3):369–78.
Steinert RE, Feinle-Bisset C, Asarian L, et al. Ghrelin, CCK, GLP-1, and PYY(3-36): secretory controls and physiological roles in eating and Glycemia in health, obesity, and after RYGB. Physiol Rev. 2017;97(1):411–63.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 A. Prodan, V. Dzyvak
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 413
Number of citations: 0
